Anthony Doyle
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biocryst Pharmaceuticals Inc (BCRX) | Former Chief Financial Officer and Treasurer | $151,925 | $2,141,135 |
| 2024 | Biocryst Pharmaceuticals Inc (BCRX) | Former Chief Financial Officer and Treasurer | $549,429 | $3,287,271 |
| 2023 | Biocryst Pharmaceuticals Inc (BCRX) | Former Chief Financial Officer and Treasurer | $528,297 | $1,790,349 |
| 2022 | Biocryst Pharmaceuticals Inc (BCRX) | Former Chief Financial Officer and Treasurer | $507,978 | $2,281,851 |
| 2021 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Financial Officer and Treasurer | $490,800 | $2,890,803 |
| 2020 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Financial Officer and Treasurer | $345,455 | $4,117,930 |
Executive changes
- 2025-04-09
-
Resigned Chief Financial Officer and Interim Principal Accounting Officer at Biocryst Pharmaceuticals Inc (BCRX)2025-04-09
- 2025-04-09
- 2023-07-10
Earnings-call appearances
-
Biocryst Pharmaceuticals Inc Q4 FY2024 Earnings Call2025-02-24
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q3 FY2024 Earnings Call2024-11-04
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q2 FY2024 Earnings Call2024-08-05
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q1 FY2024 Earnings Call2024-05-06
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q4 FY2023 Earnings Call2024-02-26
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q3 FY2023 Earnings Call2023-11-02
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q2 FY2023 Earnings Call2023-08-03
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q1 FY2023 Earnings Call2023-05-03
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q4 FY2022 Earnings Call2023-01-09
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q3 FY2022 Earnings Call2022-11-01
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q2 FY2022 Earnings Call2022-08-04
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q1 FY2022 Earnings Call2022-05-05
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q4 FY2021 Earnings Call2022-01-10
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q3 FY2021 Earnings Call2021-11-03
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q2 FY2021 Earnings Call2021-08-05
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q1 FY2021 Earnings Call2021-05-06
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q4 FY2020 Earnings Call2021-02-25
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q3 FY2020 Earnings Call2020-11-05
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q2 FY2020 Earnings Call2020-08-06
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q1 FY2020 Earnings Call2020-05-06
Biocryst Pharmaceuticals Inc (BCRX)